STAAR Surgical Co Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31)
STAAR Surgical Co (STAA) reported Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) of $5.94 million for the 12-month period ending 2014-01-03, per its 10-K filed 2014-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostCostIncurredToDate · last filed 2014-03-12
- STAAR Surgical Co restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2014-01-03 was $238.00K, a 63.72% decline year-over-year.
- STAAR Surgical Co restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2013-09-27 was $491.00K, a 32.55% decline year-over-year.
- STAAR Surgical Co restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2013-06-28 was $613.00K.
- STAAR Surgical Co restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2013-03-29 was $4.60M.
- STAAR Surgical Co restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for fiscal 2014 was $5.94M, a 60.69% increase from fiscal 2012.
- STAAR Surgical Co restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for fiscal 2012 was $3.70M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 3 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 6 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 9 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|
| 2014-01-03 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $729.00K derived: sum of 2 quarters · filed 2014-03-12 | $1.34M derived: sum of 3 quarters · filed 2014-03-12 | $5.94M 10-K · filed 2014-03-12 |
| 2013-09-27 | $491.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $1.10M derived: sum of 2 quarters · filed 2014-03-12 | $5.70M 10-Q · filed 2013-11-01 | $6.36M derived: sum of 4 quarters · filed 2014-03-12 |
| 2013-06-28 | $613.00K derived: 10-K 12 month − 3 quarters · filed 2014-03-12 | $5.21M 10-Q · filed 2013-08-06 | $5.87M derived: sum of 3 quarters · filed 2014-03-12 | $6.59M derived: sum of 4 quarters · filed 2014-03-12 |
| 2013-03-29 | $4.60M 10-Q · filed 2013-05-03 | $5.25M derived: sum of 2 quarters · filed 2013-05-03 | $5.98M derived: sum of 3 quarters · filed 2013-05-03 | |
| 2012-12-28 | $656.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $1.38M derived: sum of 2 quarters · filed 2013-03-12 | $3.70M 10-K · filed 2013-03-12 | |
| 2012-09-28 | $728.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $3.04M 10-Q · filed 2012-11-05 | ||
| 2012-06-29 | $2.31M 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |